ArticleImmunologic research2026

SIX1 drives acute myeloid leukemia progression by reprogramming glycolytic metabolism and impairing CD8⁺ T-cell effector function.

Hui Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.